Tamarack Advisers, LP Q3 2023 significant ownership

Tamarack Advisers, LP is required to file a 13D/G report to the SEC when the ownership of a company's total stock issue exceeds 5%.

Tamarack Advisers, LP Q3 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
	Filed	Shares	Percentage
STREAMLINE HEALTH SOLUTIONS INC.	June 22, 2023	5,514,515	9.4%
IVERIC bio, Inc.	February 16, 2021	850,000	0.1%
Correvio Pharma Corp.	February 14, 2020	2,500,000	4.9%
OBALON THERAPEUTICS INC	February 14, 2020	?	?
Correvio Pharma Corp.	February 15, 2019	?	?
Corium International, Inc.	February 15, 2017	737,242	3.3%
ENDOLOGIX INC /DE/^{Sold out}	February 15, 2017	0	0.0%
Imprivata Inc^{Sold out}	February 15, 2017	0	0.0%

Compare quarters

Export Tamarack Advisers, LP's holdings